Reports
Here you will find links to reports and guidelines published by our projects.
Guidelines and Documents
See resources developed by the projects including Guide for IB, IMPD, Clinical study protocol, licensing and hospital pharmacy functions, including preparation of gene therapy.
Guides and Documents | ATMP Sweden
ATMP2030 Swedish annual ATMP report 2024
Read the report ATMP annual report 2024
See the presentation recording Presentation recording
Patient- och närstående- samverkan för bättre forskning och hälso- och sjukvård
Samverkan-2-0-tillganglighet.pdf
Lägesrapport och kartläggning av utbildning och framtida kompetensbehov inom ATMP
Utbildning-och-Kompetensbehov_web.pdf
Yearly report of Nordic ATMP status, completed July 2022 by the ATMP2030 National Coordination activity
Yearly Nordic ATMP report July 2022
Read about the Swelife-ATMP initiatives towards identifying ATMP specific gaps in law, ethics and regulation, as well as identifying specific needs within healthcare, business, research and industry.
Swelife-ATMP-slutrapport-final.pdf
Infrastructure report completed March 2021 from the ATMP2030 Innovation Milieu Industrial development activity.
20210406-ATMPInfrastructure-final.pdf
Commercial aspects report completed December 2020 by the Swelife-ATMP health economics project.
Final-rapport-dec-2020_final_ENG_v3.pdf
Utmaningar och möjligheter för stamcells-baserade läkemedel i Sverige och karta över etiskt och legalt ramverk.
Slutrapport-SDP2-Swelife-ATMP.pdf
Swelife-ATMP Gene Therapy report completed February 2020 on opportunities and challenges in Swedish gene therapy.
Swelife-Gene-therapy-report-2020-02-24.pdf
Pilot Study of a Swedish Institute for Cell Therapy published late 2017.
Report on RISE ATMP pilot study_exklAppendix3